FDA re-approves USAntibiotics’ Augmentin XR, reviving domestic antibiotic access and setting CNPV precedent
FDA re-approves Augmentin XR under new priority program, restoring key antibiotic and signaling a turning point in U.S. drug supply strategy. Read more.